Avantor, Inc. (NYSE:AVTR) Short Interest Update

Avantor, Inc. (NYSE:AVTR) was the recipient of a significant drop in short interest during the month of January. As of January 31st, there was short interest totalling 26,990,000 shares, a drop of 6.1% from the January 15th total of 28,750,000 shares. Based on an average daily volume of 5,750,000 shares, the short-interest ratio is currently 4.7 days.

Avantor Stock Down 1.3 %

AVTR stock opened at $17.87 on Tuesday. Avantor has a twelve month low of $17.83 and a twelve month high of $28.00. The company has a market cap of $12.16 billion, a PE ratio of 38.84, a price-to-earnings-growth ratio of 3.87 and a beta of 1.28. The business’s 50-day simple moving average is $21.44 and its 200 day simple moving average is $23.20. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84.

Avantor (NYSE:AVTR) last released its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, topping analysts’ consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.24% and a net margin of 4.54%. During the same quarter in the prior year, the firm earned $0.22 EPS. On average, research analysts anticipate that Avantor will post 0.98 earnings per share for the current year.

Institutional Investors Weigh In On Avantor

Institutional investors have recently added to or reduced their stakes in the stock. MassMutual Private Wealth & Trust FSB boosted its holdings in Avantor by 99.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after purchasing an additional 625 shares in the last quarter. Smartleaf Asset Management LLC boosted its holdings in Avantor by 106.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock valued at $34,000 after purchasing an additional 830 shares in the last quarter. Global Retirement Partners LLC boosted its holdings in Avantor by 76.7% during the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after purchasing an additional 1,067 shares in the last quarter. Nisa Investment Advisors LLC boosted its holdings in Avantor by 69.6% during the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after purchasing an additional 835 shares in the last quarter. Finally, UMB Bank n.a. boosted its holdings in Avantor by 56.3% during the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after purchasing an additional 1,074 shares in the last quarter. 95.08% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

AVTR has been the topic of several recent research reports. Robert W. Baird cut their target price on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. Stifel Nicolaus cut their target price on Avantor from $28.00 to $26.00 and set a “buy” rating on the stock in a report on Monday, February 10th. Royal Bank of Canada cut their target price on Avantor from $33.00 to $31.00 and set an “outperform” rating on the stock in a report on Monday, February 10th. Morgan Stanley dropped their price objective on Avantor from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Monday, February 10th. Finally, Raymond James reiterated an “outperform” rating and issued a $24.00 price objective (down from $26.00) on shares of Avantor in a research note on Monday, February 10th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $25.92.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.